Total Payments
$2,040
2024 Payments
$333.16
Companies
13
Transactions
29
Medicare Patients
319
Medicare Billing
$39,224
Payment Breakdown by Category
Food & Beverage$1,606 (78.7%)
Education$433.88 (21.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,606 | 24 | 78.7% |
| Education | $433.88 | 5 | 21.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seagen Inc. | $794.56 | 8 | $0 (2023) |
| Janssen Biotech, Inc. | $309.72 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $194.70 | 2 | $0 (2021) |
| PFIZER INC. | $148.36 | 3 | $0 (2024) |
| GENZYME CORPORATION | $143.77 | 1 | $0 (2022) |
| TAIHO ONCOLOGY, INC. | $119.20 | 1 | $0 (2024) |
| AbbVie Inc. | $102.90 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $99.99 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $36.67 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.83 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $333.16 | 8 | PFIZER INC. ($148.36) |
| 2023 | $427.01 | 5 | Seagen Inc. ($327.06) |
| 2022 | $606.12 | 9 | Seagen Inc. ($243.50) |
| 2021 | $673.42 | 7 | Seagen Inc. ($224.00) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $18.82 | General |
| Category: Oncology | ||||||
| 04/13/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Oncology | ||||||
| 03/26/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $124.67 | General |
| Category: Oncology | ||||||
| 03/13/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug) | Food and Beverage | In-kind items and services | $119.20 | General |
| Category: Oncology | ||||||
| 10/26/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 09/28/2023 | Seagen Inc. | — | Education | In-kind items and services | $57.99 | General |
| 08/15/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 04/19/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $123.34 | General |
| Category: Oncology | ||||||
| 02/28/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Oncology | ||||||
| 12/09/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: ONCOLOGY | ||||||
| 09/22/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Oncology | ||||||
| 08/18/2022 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Oncology | ||||||
| 08/11/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Oncology | ||||||
| 07/20/2022 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $118.50 | General |
| Category: Oncology | ||||||
| 07/19/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $143.77 | General |
| 07/14/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Oncology | ||||||
| 05/28/2022 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Oncology | ||||||
| 04/07/2022 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 12/17/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Education | In-kind items and services | $76.95 | General |
| 11/30/2021 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $117.75 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 170 | 298 | $139,200 | $21,134 |
| 2020 | 3 | 149 | 202 | $97,250 | $18,090 |
Total Patients
319
Total Services
500
Medicare Billing
$39,224
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 112 | 240 | $106,850 | $15,259 | 14.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 33 | 33 | $23,100 | $4,193 | 18.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 25 | 25 | $9,250 | $1,682 | 18.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 70 | 70 | $49,000 | $9,120 | 18.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 65 | 118 | $43,070 | $8,003 | 18.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 14 | 14 | $5,180 | $966.84 | 18.7% |
About Dr. Mina Gendy, DO
Dr. Mina Gendy, DO is a Hematology & Oncology healthcare provider based in Hamilton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1811417868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mina Gendy, DO has received a total of $2,040 in payments from pharmaceutical and medical device companies, with $333.16 received in 2024. These payments were reported across 29 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,606).
As a Medicare-enrolled provider, Gendy has provided services to 319 Medicare beneficiaries, totaling 500 services with total Medicare billing of $39,224. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology
- Location Hamilton, NJ
- Active Since 06/21/2017
- Last Updated 06/17/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1811417868
Products in Payments
- ADCETRIS (Biological) $616.51
- DARZALEX (Biological) $293.99
- PADCEV (Biological) $153.11
- LONSURF (Drug) $119.20
- NINLARO (Drug) $117.75
- VENCLEXTA (Drug) $102.90
- FASLODEX (Drug) $99.99
- KEYTRUDA (Biological) $36.67
- REZUROCK (Drug) $26.45
- OPDUALAG (Drug) $18.82
- CABOMETYX (Drug) $17.74
- XTANDI (Drug) $16.31
- TECVAYLI (Biological) $15.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.